Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) — The “United States Vaccine Market Report 2022” Report has been added ResearchAndMarkets.com Offer.
The US vaccine market is expected to reach $30 billion by 2027, driven by COVID-19 vaccines, the development of new vaccine technologies and advances in clinical research.
The growth and approval of pediatric vaccines and universal vaccine trials have also contributed significantly to the market expansion. The Vaccine Market Report 2022 describes the entire vaccine market including the approval process, the impact of the COVID-19 pandemic, the required vaccine supplies and the market value for children, adult, influenza and COVID-19 vaccines.
Important Findings
- 11.3 billion doses of COVID-19 vaccines have been administered worldwide.
- In 2021, an estimated 11.1 million vaccinations were missed among adults and adolescents.
- Pharmacies dispensed 14.9% fewer flu vaccines in 2022 compared to 2021.
- In 2021, Pfizer sold $36 billion worth of vaccines, breaking the 2015 record of $6.2 billion.
Main topics covered:
- summary
- Overview of the vaccine market
- Vaccines make an important contribution to pharmacy sales
- Pharmacy technicians nationwide now licensed to vaccinate
- Insurance or government programs cover most recommended vaccines
- The influenza vaccine market is expected to recover from the pandemic
- More adults are vaccinated against influenza in pharmacies than in doctor’s offices
- The pandemic continues to suppress influenza vaccination, including in high-risk groups
- Universal flu vaccine candidate could wipe out annual vaccinations
- First cell-based influenza vaccine offers better adaptation to circulating strains
- COVID-19 vaccine market remains strong
- First COVID-19 vaccines approved, more in development
- 2021 COVID-19 mRNA Success Promotes Nucleic Acid Vaccines for Other Diseases
- COVID-19 vaccines are rising in price
- COVID-19 vaccine recruitment is shifting away from non-traditional megasites
- Vaccination requirements in the workplace remain controversial
- CDC Research points to the need for four or more COVID-19 doses.
- COVID-19 vaccine split extends to rural…
